CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Prevention of prolonged labor by active management of first stage using spasmolytic drugs a double blind randomized controlled clinical study

Author: 
Ahmed A. M. Nasr and Mahmoud Fouad
Subject Area: 
Health Sciences
Abstract: 

Background: Dystocia remains the most common indication for emergency cesarean section especially for primigravidae. As such, it is a major contributor to operative and instrumental intervention. Type of Study: A double-blind, randomized, controlled clinical trial. Objective: This study aimed to evaluate the effect of 2 spasmolytic drugs, Drotaverine and Hyoscine-N-Butylbromide on shortening of first stage of labor. Setting: Obstetrics and Gynecology Departments of Al-Azhar university hospital (Assiut), Egypt. Patients & Methds: 150 full term primigravidae in labor (cervical dilatation 3-4cm with regular progressive uterine contractions 3-4/ 10 minutes, each lasting for at least 40 seconds) were recruited for this study during the period from June 2018 to december 2018. Patients were divided into three equal groups (50 patients for each). Group I: Received (40mg) drotaverine hydrochloride by slowly IV infusion. Group II: Received (20mg) hyoscine-n-butylbromide by slowly IV infusion. Group III: (control): Received Sterile water for injection (placebo). Results: the rate of cervical dilation was significantly higher in group 1&II compared to the control group; also duration of 1st stages was significantly shorter in the same groups while no significant difference in duration of 2nd stage were present among the 3 groups, the degree of severe pain and the need for oxytocin augmentation doses were significantly lesser in both groups compared to control (p<0.001). The neonatal outcomes in the form of APGAR score was higher and need for NICU admission was significantly lower in group I&II compared to group III. Conclusion: both drugs used in this study have significant effects on shortening of 1st stage of labor with lesser units of oxytocin needed for augmentation with good analgesic effect and good neonatal outcome, however, Drotaverine hydrochloride was better as it was more effective beside it has the strongest labor pain relieve and lesser maternal adverse effects. Recommendations: We recommend using of either drug in enhancing first stage of labor however; Drotaverine hydrochloride is preferable as it is more effective with minimal maternal adverse effects.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran